A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure

PHASE4CompletedINTERVENTIONAL

Enrollment

450

Participants

Timeline

Start Date

February 28, 1999

Study Completion Date

September 30, 2000

Conditions

Graft RejectionKidney Transplantation

Interventions

DRUG

tacrolimus

Trial Locations (18)

Los Angeles

San Diego

San Francisco

Denver

New Haven

Augusta

Chicago

Lexington

Baltimore

Boston

Minneapolis

Albany

New York

Portland

Philadelphia

Nashville

Salt Lake City

Madison